Evidence map›Paper›PMID 30355671›Full record

ArticlemSphere2018

Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.

Alessandro Tanca, Antonio Palomba, Cristina Fraumene, Valeria Manghina, Michael Silverman, Sergio Uzzau

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
  4. T-Cell Receptor Sequences Identify Combined Coxsackievirus-International journal of molecular sciences · 2024
    Article
  5. Article
  6. International journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A metagenome-wide association study of gut microbiome and visceral fat accumulation.Computational and structural biotechnology journal · 2020
    Article
  16. Review
  17. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.International journal of molecular sciences · 2019
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alessandro TancaPorto Conte Ricerche, Tramariglio, Alghero, Italy.
Antonio PalombaPorto Conte Ricerche, Tramariglio, Alghero, Italy.
Cristina FraumenePorto Conte Ricerche, Tramariglio, Alghero, Italy.
Valeria ManghinaDipartimento di Scienze Biomediche, Università di Sassari, Sassari, Italy.
Michael SilvermanDivision of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Sergio UzzauPorto Conte Ricerche, Tramariglio, Alghero, Italy uzzau@portocontericerche.it.
Consorzio Futuro in Ricerca · ITBoston Children's Hospital · USUniversity of Sassari · IT

Funding

Transfer: Dissecting the interplay of MHC/HLA loci, the microbiota and autoimmune diabetesK08AI114970 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI SILVERMAN, MICHAEL A · 2015 to 2019
$893k
NIAID NIH HHS K08 AI114970
6 · The paper itself

Abstract

Increasing evidence suggests that the intestinal microbiota is involved in the pathogenesis of type 1 diabetes (T1D). Here we sought to determine which gut microbial taxa and functions vary between nonobese diabetic (NOD) mice and genetically modified NOD mice protected from T1D (Eα16/NOD) at 10 weeks of age in the time window between insulitis development and T1D onset. The gut microbiota of NOD mice were investigated by analyzing stool samples with a metaproteogenomic approach, comprising both 16S rRNA gene sequencing and microbial proteome profiling through high-resolution mass spectrometry. A depletion of

Indexed as

ClostridiumAnimalsButyratesDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Gastrointestinal MicrobiomeMiceMice, Inbred NODButyratesbutyratediabetesmetaproteomicsmicrobiomeshort-chain fatty acids

Identifiers

PMID30355671
PMCPMC6200989
OpenAlexW2897596394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.